OVID - Ovid -13% on common preferred offerings October, 03 2019 04:18 PM Ovid Therapeutics Inc. Ovid Therapeutics (NASDAQ:OVID) has tumbled 13.1% postmarket after announcing public offerings of common stock and preferred stock.More news on: Ovid Therapeutics Inc., Healthcare stocks news, Stocks on the move, Read more ...